Skip to content

Released May 14, 2012, after the close

10-Q filed May 14, 2012, 44 days after period end · 0001193125-12-231316

Q1 2012 · 10-Q
Revenue$2.75Mno prior Q1 2011 on fileno prior Q4 2011 on file
Net Income-$10.54MN/M vs Q1 2011N/M vs Q4 2011
EPS Diluted-$0.52N/M vs Q1 2011no prior Q4 2011 on file
Gross Profit$2,357,000—
Operating Cash Flow-$4,885,000N/M
Margins · derived
Gross margin85.7%
Net margin-383.2%

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ1 2012Q1 2011
Revenue$2.75M—
Net Income-$10.54M-$3.84M
EPS Diluted-$0.52-$0.19

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

SELLAS Life Sciences Group, Inc. · CIK 1390478 · Engraved from SEC EDGAR